Modified DIMS glasses for myopia in children
Official title: Choroidal Responses to the Modified Defocus Incorporated Multiple Segments (DIMS) Spectacle Lenses
Run by The Hong Kong Polytechnic University · NCT07547072 · Data updated 2026-11-12
This study tests whether two versions of modified DIMS spectacle lenses can influence choroidal thickness and eye growth in 6- to 13-year-olds with myopia.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 6 Years to 13 Years |
| Sex | All |
| Enrollment | 108 (estimated) |
| Sponsor | The Hong Kong Polytechnic University Academic / other |
| Locations | 1 site (Kowloon, Hong Kong) |
| Status | Recruiting |
| Started | April 24, 2026 |
| Main results expected | December 31, 2027 |
| Study ends | February 29, 2028 |
| Registry record updated | September 17, 2026 |
| Trial ID | NCT07547072 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Hong Kong Chinese children aged 6–13 with myopia between -1.00D and -5.00D, limited astigmatism, and documented myopia progression.
✕Probably not a fit
Children with higher astigmatism, poor binocular vision, or who do not wear lenses consistently may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Children with myopia will be randomized to wear one of two modified DIMS lenses (D1 or D2) or standard single-vision lenses for daily use over 12 months. Weekly checks in the first month will monitor choroidal thickness and other eye measurements, followed by visits at 1, 6, and 12 months to track refraction and axial length. The study aims to see if the modified lenses can affect choroidal thickness and myopia progression differently than standard lenses. Cycloplegic refraction and axial length will be measured every six months. The investigation builds on prior DIMS-type optical approaches to myopia control in children and uses a randomized design to compare multiple lens types.
Why it matters
Potential benefit: If successful, the lenses could offer a safe option to slow myopia progression and inform personalized lens choices for children.
How similar studies have gone: Previous DIMS-based approaches have shown promise in slowing myopia progression in children, but performance can vary by individual.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Hong Kong Chinese * Age at enrolment: 6 - 13 years * Myopia in spherical power: -1.00D to -5.00D in both eyes * Astigmatism: equal or less than 2.00D * The sum of spherical power and astigmatism: equal or less than -7.00D * Anisometropia (spherical equivalent refraction (SER)): equal or less than 1.50D * Previous myopia progression (valid documentation dated within 2 years before screening): * -0.50D (SER) per year or more in both eyes OR Axial length elongation: 0.27mm/year in both eyes * If myopia is initially detected during screening, eligibility requires myopia (in SER) below the 3rd percentile curve of refraction in both eyes.12 * Best corrected visual acuity: LogMAR 0.04 or better in both eyes * Ocular health: no abnormalities in both internal and external ocular health * Binocular vision: no strabismus and other binocular abnormalities * Normal colour vision * Willing to wear the study spectacles all the time (10 hours per day, for 7 days per week) Exclusion Criteria: * Previous or current treatment for myopia control (e.g., red-light therapy, atropine, orthokeratology, specialized spectacle lenses and contact lenses and oral supplements for myopic control) * Existing or past eye diseases or surgeries (e.g., strabismus surgery, amblyopia, oculomotor nerve palsies, corneal disease, intraocular disease, etc.) that may have an impact on vision or visual development * Long-term medication (intake at least 3 days/week) or medication/supplements that affect eye health * Systemic diseases that may have an impact on vision or visual development (e.g., endocrine, cardiac and respiratory diseases, diabetes, Down syndrome, etc.) * Allergic to cyclopentolate eye drops * Individuals who, in the judgment of the Investigator, are unable to cooperate and follow instructions during eye examination.
Where it's running
-
Optometry Research Clinic, School of Optometry, The Hong Kong Polytechnic University
Kowloon, Hong Kong, Hong Kong Recruiting
Study contacts
- Principal investigator: Rachel Ka Man Chun, PhD — School of Optometry, The Hong Kong Polytechnic University
- Study coordinator: Rachel Ka Man Chun, PhD
- Email: rachel.chun@polyu.edu.hk
- Phone: 852-27664224
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating a device for screening vision problems in young children
This study is testing a new device to see if it can effectively find vision problems in children aged 3 to 8, whether they wear glasses or not.
-
Optimizing light exposure to prevent and control myopia in children
This study tests if changing classroom lighting to mimic sunlight or using a smartphone app to guide light exposure can help prevent and control myopia in primary school children.
-
Hyperopic reserve screening for kindergartners in Beijing
A population-wide screening tests whether senior kindergarten children in Beijing have enough hyperopic reserve to help prevent future myopia.
-
Do dual-focus multifocal contact lenses improve hand-eye coordination and sports vision compared with your usual lenses
This study tests whether wearing dual-focus multifocal contact lenses improves hand-eye coordination and sports vision in adults who play baseball or softball and normally wear contact lenses.
-
Two monthly silicone hydrogel multifocal toric contact lenses in wearers with astigmatism and myopia
This study tests whether two popular soft multifocal toric contact lenses perform differently in adults who need vision correction for astigmatism and myopia.
-
Seeing clearly in low light after Ray-Tracing guided LASIK
A trial tests how well WaveLight Plus LASIK works for people with myopia and astigmatism and whether patients are satisfied after the procedure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.